US 11,981,954 B2
Compositions and methods for rapid identification and phenotypic antimicrobial susceptibility testing of bacteria and fungi
Kyle C. Cady, Santa Clara, CA (US); Brett Hanson, Milpitas, CA (US); Paulino Abdon, Los Gatos, CA (US); Ryan Chan, San Jose, CA (US); Patrick Lin, San Jose, CA (US); Rochak Mehta, Fremont, CA (US); and Troy Rabang, Campbell, CA (US)
Assigned to Roche Molecular Systems, Inc., Pleasanton, CA (US)
Filed by Roche Molecular Systems, Inc., Pleasanton, CA (US)
Filed on Jul. 13, 2022, as Appl. No. 17/812,380.
Application 17/812,380 is a continuation of application No. 16/950,160, filed on Nov. 17, 2020, granted, now 11,441,167.
Claims priority of provisional application 62/938,144, filed on Nov. 20, 2019.
Prior Publication US 2022/0364140 A1, Nov. 17, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. C12P 19/34 (2006.01); C12Q 1/18 (2006.01); C12Q 1/689 (2018.01); C12Q 1/6895 (2018.01); C12Q 1/6897 (2018.01); C12Q 1/6851 (2018.01); C12Q 1/686 (2018.01)
CPC C12Q 1/18 (2013.01) [C12Q 1/689 (2013.01); C12Q 1/6895 (2013.01); C12Q 1/6897 (2013.01); C12Q 1/6851 (2013.01); C12Q 1/686 (2013.01); C12Q 2561/101 (2013.01); C12Q 2561/113 (2013.01); C12Q 2565/1015 (2013.01); C12Q 2600/136 (2013.01)] 19 Claims
 
1. A method to simultaneously identify and determine the antimicrobial susceptibility for one or more antimicrobial(s) of two or more different microorganisms in a biological sample comprising:
a) obtaining the biological sample in which the two or more different microorganisms are believed to be present;
b) optionally culturing the biological sample under conditions that facilitate growth of the two or more different microorganisms and optionally normalizing the cultured biological sample such that the two or more different microorganisms reach a desired concentration;
c) adding the biological sample in two or more reaction wells, whereby the one or more antimicrobial(s) is absent in at least one reaction well, and whereby the one or more antimicrobial(s) is present in one or more reaction wells at one concentration or at more than one varying concentrations, wherein in at least one reaction well, the concentration of the one or more antimicrobial(s) is either the Minimum Inhibitory Concentration (MIC) or the concentration used to classify the two or more different microorganisms as Sensitive, Intermediate or Resistant to the one or more antimicrobial(s);
d) incubating the biological sample in the presence or absence of the one or more antimicrobial(s) for a period of time required to detect inhibition of growth;
e) performing a quantitative real-time PCR assay in each of the two or more reaction wells, whereby, each PCR assay comprises:
(i) an amplifying step with at least a first set of primers and a second set of primers, wherein the first set of primers selectively anneals to a first target gene in a first microorganism and produces a first amplification product if the first microorganism is present in the biological sample, and wherein the second set of primers selectively anneals to a second target gene in a second microorganism and produces a second amplification product if the second microorganism is present in the biological sample, and
(ii) a hybridizing step wherein a first detectable probe labeled with a first fluorescent dye selectively anneals to the first amplification product and generates a first signal and a second detectable probe labeled with a second fluorescent dye selectively anneals to the second amplification product and generates a second signal that is distinguishable from the first signal;
f) identifying the two or more different microorganisms whereby detection of the first signal is indicative of the presence of the first microorganism and detection of the second signal is indicative of the presence of the second microorganism; and
g) determining the antimicrobial susceptibility of the two or more different microorganisms by comparing the first and second signals detected in the at least one reaction well where the one or more antimicrobial(s) is absent to the first and second signals detected in the one or more reaction well(s) where the one or more antimicrobial(s) is present;
wherein steps e), f), and g), are all performed simultaneously in each of the two or more reaction wells.